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Abstract. Neuroblastoma cell line SH-SY5Y, due to its capacity to differentiate into neurons, easy handling, and low cost, is a
common experimental model to study molecular events leading to Alzheimer’s disease (AD). However, it is prevalently used
in its undifferentiated state, which does not resemble neurons affected by the disease. Here, we show that the expression and
localization of amyloid- protein precursor (APP), one of the key molecules involved in AD pathogenesis, is dramatically
altered in SH-SY5Y cells fully differentiated by combined treatment with retinoic acid and BDNF. We show that insufficient
differentiation of SH-SY5Y cells results in APP mislocalization.
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INTRODUCTION
Alzheimer’s disease (AD) is the most common
form of dementia characterized by memory loss and
cognitive decline [1]. Despite intensive research over
the last few decades, the exact molecular mechanism
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describing the development of AD is not sufficiently
clarified. Thus, there is an urgent need for suitable in
vitro AD models. For characterization of fundamen-
tal molecular events and processes involved in AD
development, a simple cell-based system is required.
Inducible pluripotent human stem cells (iPSC), which
are subsequently differentiable into neurons, rep-
resent physiologically highly relevant model, but
their wider use is limited by uncertain differentiation
efficiency and higher experimental costs [2]. There-
fore, well-established cell lines are often selected by
many researchers. Among those, chromosomally sta-
ble human neuroblastoma SH-SY5Y is probably the
most common [3].
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Undifferentiated SH-SY5Y cells are non-pola-
rized, rapidly proliferative and do not express mature
neuronal markers. These neuroblastoma cells can be
differentiated into mature neurons through several
established protocols; e.g., serum deprivation, treat-
ment with retinoic acid (RA), 12-O-tetradecanoyl-
phorbol-13-acetate (TPA), dibutyryl cyclic AMP
(dbcAMP), or specific neurotrophins (brain-derived
neurotrophic factor (BDNF) or nerve growth fac-
tor (NGF)) [4–10]. During SH-SY5Y differentiation
into functional neurons, cells adopt a neuronal mor-
phology characterized by a reduction of the cell
body size and extension of branched neurites that
are interconnected into functional networks [6, 11].
Full differentiation of SH-SY5Y cells alter their prop-
erties and have an impact on survival and stress
signaling pathways [12]. Significant changes in gene
and miRNA expression have been reported for RA
treatment alone [13]. RA differentiation followed by
BDNF (RA/BDNF) treatment results in even stronger
changes in expression of many genes, including those
encoding neuronal markers such as tau, synaptostatin,
and synaptophysin [6, 11–14]. Even though the pres-
ence of amyloid plaques composed of amyloid-
(A) peptide derived from amyloid- protein pre-
cursor (APP) is one of the main hallmarks of
AD [15–17], the impact of neuronal differentiation
(RA/BDNF) on APP distribution and processing
has not been studied.
In 2019, only 2% of published works used fully
differentiated SH-SY5Y cells (RA + BDNF); in 76%
of cases, the undifferentiated cells were used. This
practice did not change with time [13]. The applied
method of differentiation may strongly affect APP
expression, processing and its localization, and there-
fore influence the experimental outcome. We have
thus investigated the effect of differentiation on APP
expression and distribution and tested functionally
associated proteins. We demonstrate that undifferen-
tiated cells show important distinctions compared to
fully differentiated, neuron-like SH-SY5Y cells.
METHODS
Cell culture and treatment
SH-SY5Y cells (ECACC, 94030304) were grown
in high glucose Dulbecco’s Modified Eagle’s medium
(DMEM; Sigma-Aldrich, D6429) supplemented with
10% heat-inactivated fetal bovine serum (FBS;
Gibco, 10270-106) in a humidified incubator (Eppen-
dorf) at 37◦C and 5% CO2. Cells were routinely
split 3 times a week at 80–90% confluence. All
SH-SY5Y cells used in this study were at a low
passage number (< 15) and tested for mycoplasma
contamination. Cellular differentiation was induced
as described by Hromadkova et al., 2020 [11] with
minor modifications. Briefly, 5 × 104 cells/cm2 in
DMEM with 5% FBS were grown on coverslips or
in treated T25 flasks. After three days, the media was
replaced with DMEM containing 2% FBS and 10 M
all-trans-retinoic acid (RA; Sigma-Aldrich, R2625)
and cultured for another 5 days. For the full differ-
entiation, cells were washed thoroughly with PBS,
the medium was replaced with Neurobasal medium
(Thermo Fisher Scientific, 21103049) supplemented
with N-2 supplement (Thermo Fisher Scientific,
17502001) and 50 ng/ml BDNF (Thermo Fisher Sci-
entific, PHC7074) and the cells were cultured for
another 7–9 days. We refer to the three phases of dif-
ferentiation: 1) undifferentiated cells (UN); 2) cells
differentiated with retinoic acid for 5 or 6 days (RA);
and 3) followed by BDNF treatment (RA/BDNF).
Immunofluorescence
Cells were grown on poly-D-lysine-coated cov-
erslips, rinsed with preheated PBS and fixed with
fixation solution (4% paraformaldehyde, Electron
Microscopy Sciences, 15714; 2% sucrose, Sigma-
Aldrich, S7903; in PBS). After quenching with
50 mM NH4Cl in PBS, cells were washed several
times with PBS and then permeabilized with 0.2%
Triton X-100 in PBS for 10 min at room temperature
(this last step was skipped in the case of membrane
APP quantification experiments). After blocking
with 1% bovine serum albumin in PBS for 30 min
at room temperature (RT), cells were incubated with
primary antibodies at 4◦C overnight. Coverslips were
then washed with PBS and incubated with a sec-
ondary antibody conjugated to a fluorescent probe in
darkness for 1 h at RT. After several washing steps,
cells were incubated with 300 nM DAPI in PBS for
5 min.
For colocalization analysis of APP with mito-
chondria, cells were incubated in full growth media
containing 50 nM MitoTracker Red FM (Thermo
Fisher Scientific, M22425) for 20 min at 37◦C and
then fixed. For visualization of the Golgi apparatus,
cells were transfected with 6 g of the mApple-
Golgi-7 (gift from Michael Davidson; Addgene
plasmid # 54907) using FuGene HD Transfection
Reagent (Promega, E2311).
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Fig. 1. Changes in APP expression in SH-SY5Y cells upon differentiation. A) Western blots showing increased expression of Tau upon
full differentiation with RA and BDNF and Syn (synaptophysin) upon RA treatment. Antibodies: anti-tau, AXON Neuroscience, DC25;
Anti-Syn, Abcam, ab32594; Anti-GAPDH, Merck, ABS16. B) Box-plot of cell perimeter changing with a differentiation state. Cell perime-
ters were determined using particle analysis plugin in ImageJ. C) Immunoblot showing full lengths APP protein levels (antibody to
N terminus; aa 66–81: clone 22C11, Merck, MAB348) in SH-SY5Y cells differentiated with RA or RA/BDNF. APP mRNA levels
were determined in total RNA extract by RT-qPCR. The expression of APPFL was normalized to the GAPDH data from 4 (WB), or
3 (RT-qPCR) independent experiments; error bars represent standard error of the mean. D) Representative immunofluorescence images
of SH-SY5Y cells treated (or not) with RA or RA/BDNF. The scale bar 10 m. The graph shows integrated signal for APP quantified
from the images of fixed, immunofluorescently-labeled SH-SY5Y cells (same antibody as in C). Final intensity values were normalized
with respect to the total cell area. E) BACE1 protein (antibody: Cell Signaling Technology, D10E5) and mRNA levels at different dif-
ferentiation states. UN, undifferentiated cells; RA, cells differentiated with retinoic acid; RA/BDNF, cells differentiated with RA and
BDNF.
Cells were imaged on a home-built widefield flu-
orescence microscope setup (IX71, Olympus) equi-
pped with 100x TIRF objective (UAPON, NA = 1.49,
Olympus), 405, 643 nm (both Cube, Coherent),
488, 561 nm (both Sapphire, Coherent) lasers and
iXon DU-897 EMCCD camera (Andor). Membrane
APP was imaged by total internal reflection flu-
orescence microscopy with 60x TIRF objective
(UPLAPO60HR, NA = 1.5, Olympus). System was
controlled using a home programmed software based
on the LabVIEW interface (version 2011). For further
processing images were z-projected by the averaging
method in ImageJ [18, 19]. Wavelet-based back-
ground subtraction method [20] was used to remove
intracellular signal in the case of membrane APP
quantification.
Western blotting, real time PCR analysis, super-
resolution imaging, and table with primer sequences
are described in the Supplementary Material.
RESULTS
To determine the efficiency of our differentiation
method, we have first monitored the expression of
well-established neuronal markers and morpholog-
ical characteristics of treated SH-SY5Y cells. Tau
and Synaptophysin expression levels increased sig-
nificantly upon combined treatment with RA and
BDNF (Fig. 1A), suggesting effective differentiation
of SH-SY5Y cells into neuron-like cells. RA/BDNF
treatment, but not with RA alone, also dramatically
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changed cell morphology (Fig. 1B, D). We concluded
that treatment with RA followed by BDNF resulted
in a differentiated neuronal line.
To verify the hypothesis that a adequate study
of AD-related protein distribution and dynamics in
neuroblastoma cells requires their effective differen-
tiation, we monitored changes in the expression of full
length APP (APPFL) by combination of quantita-
tive protein and RNA analysis. By immunoblotting
with antibody to the N-terminal part, we confirm that
RA differentiation of SH-SY5Y increases APPFL
expression levels (Fig. 1C) [21]. However, fully
differentiated RA/BDNF (12-days) cells express a
significantly lower level of APPFL compared to
untreated (UN) or RA-treated cells (Fig. 1C). The
observed reduction of intracellular APP was con-
firmed by quantitative fluorescence microscopy of
fixed immuno-labeled SH-SY5Y cells (Fig. 1D). The
abundance of membrane APP was reduced accord-
ingly (data not shown). Interestingly, the decrease
in protein expression in fully differentiated cells is
not due to the changes in mRNA levels, as revealed
by RT-qPCR (Fig. 1C). This indicates that APP is
rapidly processed by proteases in fully differentiated
SH-SY5Y cells. We also quantified the abundance
of APP proteolytic product A peptide. Immuno-
labeling of fixed cells was used (Merck, AB5078P)
and A abundance in UN, RA, and RA/BDNF cells
was determined by fluorescence microscopy. We did
not see any significant changes in A levels for dif-
ferent treatment methods (data not shown). Next, we
have found that the expression of BACE1 protease
involved in amyloidogenic processing of APP is
increased after RA, but strongly reduced by further
BDNF treatment (Fig. 1E). This is in line with the ear-
lier observation that RA-treatment of SH-SY5Y cells
followed by BDNF promotes proteolytic processing
of APP with a preference for non-amyloidogenic
cleavage and that higher abundance of sAPP
inhibits the activity of BACE1 leading to lower levels
of A fragments [22].
We have further analyzed distribution of APP
in SH-SY5Y cells at different stages of differenti-
ation using single molecule localization microscopy
with spatial resolution bellow 50 nm (Fig. 2A). In
UN and RA cells, the fluorescent signal is localized
to the perinuclear region, while in RA/BDNF cells
the signal is spread more over the cell body. This
is in agreement with wide-field imaging data, which
exhibit lower resolution (Fig. 1D). Broader distri-
bution indicates altered association of APP with
intracellular organelles in fully differentiated SH-
SY5Y cells. We thus tested colocalization of APP
with two organelles, where APP has been reported
previously—the Golgi apparatus and mitochondria
[23–25] (Fig. 2B, C). The colocalization values
between APP and the Golgi apparatus, mitochon-
dria, or nucleus (control) are plotted in Fig. 2D. In UN
and RA-differentiated cells, APP does not exhibit
significant colocalization with the Golgi apparatus or
mitochondria markers. On the contrary, APP sig-
nificantly overlaps with both the Golgi apparatus and
mitochondria in RA/BDNF-treated cells (Fig. 2B-D).
Indeed, mitochondria appear to be the preferred target
for APP localization in such neuron-like SH-SY5Y
cells. Very low overlap values with the nucleus in
RA/BDNF-treated cells further support the finding
that APP does not accumulate in the perinuclear
region of fully differentiated SH-SY5Y cells.
DISCUSSION
The use of SH-SY5Y as a model cell line for AD
studies requires detailed understanding of molecular
pathways involved in cell function and neurodegen-
eration. These aspects are expected to be affected by
their differentiation state. In this work, we focused
on characterization of APP in SH-SY5Y cells upon
diverse differentiation methods. Previously, various
neuronal cell lines (PC12, P19, or N27) were char-
acterized with respect to their intrinsic properties
like sensitivity to neurotoxins and oxidative stress or
functional parameters such as the presence of active
neurotransmitter receptors and ion channels [26–28].
However, differentiation into neuronal phenotype has
not been considered in these studies. For SH-SY5Y
cells, it has been reported that the method of cultiva-
tion, treatment and neuronal induction plays a critical
role in the resulting phenotype [29, 30].
RA-based differentiation of SH-SY5Y cells
induces TrkB receptor expression. TrkB activation
is induced by neurotrophins, like BDNF, and triggers
morphological changes towards neuronal phenotype
[31]. Our results confirm that stimulation with BDNF
after the initial RA-treatment led to a cell population
with characteristics of mature neurons. Compared
to cells treated with RA alone, fully differentiated
cells (RA/BDNF) formed extended neurites, which
were accompanied by increased cell perimeter and,
importantly, expression of mature neuronal mark-
ers. The generally accepted consensus is that APP
localizes to the Golgi apparatus and vesicles of the
endo-lysosomal pathway in the perinuclear region.
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Fig. 2. Differentiation affects the distribution of APP in SH-SY5Y cells. A) High-resolution APP localization was determined in
immunolabeled (see Fig. 1), undifferentiated (left), RA differentiated (middle), and RA/BDNF differentiated (right) SH-SY5Y cells using
super-resolution method – single molecule localization microscopy. N-terminal part of APP – magenta, nucleus – blue, cell contour – white
line. The scale bar represents 10 m. B, C) Two-channel, wide-field images of APP in fixed SH-SY5Y cells. Green color in merged images
corresponds to the Golgi (B)/Mitochondria (C) markers, magenta – N-terminal part of APP. The white contour shows the edge of the cell.
UN, undifferentiated cells; RA, cells differentiated with retinoic acid; RA/BDNF, cells differentiated with RA and BDNF. Scale bars, 10 m.
D) APP colocalization with Golgi apparatus, mitochondria and nucleus characterized as the M1 values using JACoP algorithms (for details,
see Methods). The values were calculated from at least four independent experiments.
Here, we have presented that APP delocalizes from
the perinuclear region and preferentially colocal-
izes with mitochondria in fully differentiated cells
(RA/BDNF). This is associated with decreased levels
of full-length APP, which is probably processed in a
non-amyloidogenic proteolytic pathway as reported
earlier [22].
Indeed, apart from the effects of the differenti-
ation of SH-SY5Y cell on APP distribution and
proteolytic processing mentioned, there is evidence
suggesting considerable effect of RA/BDNF treat-
ment on protein machinery of SH-SY5Y cells,
implicated in pathobiology of AD. Moreover,
RA/BDNF differentiated cells have been shown
to display higher susceptibility to A toxicity as
compared to undifferentiated precursors [4]. The rea-
sons for these are alternations in oxidative stress
response [14] as well as changes in intracellular dis-
tribution and phosphorylation of another AD related
protein tau [32]. These reports further consolidate our
conclusion that the SH-SY5Y cell line is a superb in
vitro model of addressing specific questions related
to the biology of AD, assuming that methods of cul-
tivation and testing are carefully selected.
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